Guardat en:
Dades bibliogràfiques
Autors principals: Aravind, Nandakumar, Deepa, K, Sudhir, A, Chintu Mary, Mathew, Shubha, Jayaram, B. K. Manjunatha, Goud, Gulam Saidunissa, Begum
Format: Recurso digital
Idioma:anglès
Publicat: Zenodo 2026
Matèries:
Accés en línia:https://doi.org/10.5281/zenodo.20323607
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
_version_ 1866901849032884224
author Aravind, Nandakumar
Deepa, K
Sudhir, A
Chintu Mary, Mathew
Shubha, Jayaram
B. K. Manjunatha, Goud
Gulam Saidunissa, Begum
author_facet Aravind, Nandakumar
Deepa, K
Sudhir, A
Chintu Mary, Mathew
Shubha, Jayaram
B. K. Manjunatha, Goud
Gulam Saidunissa, Begum
contents <p class="MsoNormal">Carcinoma of breast is the second most common cause of cancer-related mortality. A hallmark of breast cancer is metabolic pathway reprogramming. It enables progression, metastasis and resistance to conventional therapies. Lactate Dehydrogenase (LDH) is upregulated in rapidly growing tumours to maintain glycolysis as an alternative source of energy. Serum ferritin level perturbations are associated with rapid progression by promoting neoplastic cell transformation. Elevated alkaline phosphatase levels indicate a heavy tumour burden and distant metastasis. Cross sectional study was done on 60 patients diagnosed with breast cancer admitted to Surgery Department at K R Hospital, Mysore between June and August 2022 and were subjected to TNM staging. 2 ml of venous blood sample was collected and analyzed for LDH, Ferritin and ALP by enzymatic method using fully automated analyzer. The results are expressed as Mean ± Standard deviation. p<0.001 is considered statistically significant. Statistical analysis was performed using One Way ANOVA and independent sample ‘t’ test. The present study shows statistically significant increase in serum LDH, ferritin and ALP levels in patients with metastatic breast cancer with mean standard deviation of 505.53 ± 110.50 (U/L), 902.01 ± 257.57 (ng/ml) and 344.68 ± 91.86 (U/L) respectively. The values of LDH, ferritin and ALP is significantly increased statistically in patients with metastatic breast cancer. Owing to the need of detecting cancer onset and progression from the early stages in areas especially where sophisticated imaging and analysis are not easily available, the identification of blood-based biomarkers is appealing.> <0.001 is considered statistically significant. Statistical analysis was performed using One Way ANOVA and independent sample ‘t’ test. The present study shows statistically significant increase in serum LDH, ferritin and ALP levels in patients with metastatic breast cancer with mean standard deviation of 505.53 ± 110.50 (U/L), 902.01 ± 257.57 (ng/ml) and 344.68 ± 91.86 (U/L) respectively. The values of LDH, ferritin and ALP is significantly increased statistically in patients with metastatic breast cancer. Owing to the need of detecting cancer onset and progression from the early stages in areas especially where sophisticated imaging and analysis are not easily available, the identification of blood-based biomarkers is appealing.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_20323607
institution Zenodo
language eng
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle Assessment of tumor activity in breast cancer patients: A study of serum lactate dehydrogenase, ferritin and alkaline phosphatase levels at a tertiary care hospital
Aravind, Nandakumar
Deepa, K
Sudhir, A
Chintu Mary, Mathew
Shubha, Jayaram
B. K. Manjunatha, Goud
Gulam Saidunissa, Begum
LDH; Ferritin; ALP; Breast cancer; Metastasis
<p class="MsoNormal">Carcinoma of breast is the second most common cause of cancer-related mortality. A hallmark of breast cancer is metabolic pathway reprogramming. It enables progression, metastasis and resistance to conventional therapies. Lactate Dehydrogenase (LDH) is upregulated in rapidly growing tumours to maintain glycolysis as an alternative source of energy. Serum ferritin level perturbations are associated with rapid progression by promoting neoplastic cell transformation. Elevated alkaline phosphatase levels indicate a heavy tumour burden and distant metastasis. Cross sectional study was done on 60 patients diagnosed with breast cancer admitted to Surgery Department at K R Hospital, Mysore between June and August 2022 and were subjected to TNM staging. 2 ml of venous blood sample was collected and analyzed for LDH, Ferritin and ALP by enzymatic method using fully automated analyzer. The results are expressed as Mean ± Standard deviation. p<0.001 is considered statistically significant. Statistical analysis was performed using One Way ANOVA and independent sample ‘t’ test. The present study shows statistically significant increase in serum LDH, ferritin and ALP levels in patients with metastatic breast cancer with mean standard deviation of 505.53 ± 110.50 (U/L), 902.01 ± 257.57 (ng/ml) and 344.68 ± 91.86 (U/L) respectively. The values of LDH, ferritin and ALP is significantly increased statistically in patients with metastatic breast cancer. Owing to the need of detecting cancer onset and progression from the early stages in areas especially where sophisticated imaging and analysis are not easily available, the identification of blood-based biomarkers is appealing.> <0.001 is considered statistically significant. Statistical analysis was performed using One Way ANOVA and independent sample ‘t’ test. The present study shows statistically significant increase in serum LDH, ferritin and ALP levels in patients with metastatic breast cancer with mean standard deviation of 505.53 ± 110.50 (U/L), 902.01 ± 257.57 (ng/ml) and 344.68 ± 91.86 (U/L) respectively. The values of LDH, ferritin and ALP is significantly increased statistically in patients with metastatic breast cancer. Owing to the need of detecting cancer onset and progression from the early stages in areas especially where sophisticated imaging and analysis are not easily available, the identification of blood-based biomarkers is appealing.</p>
title Assessment of tumor activity in breast cancer patients: A study of serum lactate dehydrogenase, ferritin and alkaline phosphatase levels at a tertiary care hospital
topic LDH; Ferritin; ALP; Breast cancer; Metastasis
url https://doi.org/10.5281/zenodo.20323607